TP53 and breast carcinoma: We demonstrated that 9-cis-retinoic acid combined with Rosiglitazone (BRL) provoked intrinsic apoptosis in MCF7, SK-BR-3 and T47D breast cancer cells in a p53-dependent manner [104].